232 related articles for article (PubMed ID: 30904045)
1. CXCR4 and CCR7 Expression in Primary Nodal Diffuse Large B-Cell Lymphoma-A Clinical and Immunohistochemical Study.
Du H; Zhang L; Li G; Liu W; Tang W; Zhang H; Luan J; Gao L; Wang X
Am J Med Sci; 2019 Apr; 357(4):302-310. PubMed ID: 30904045
[TBL] [Abstract][Full Text] [Related]
2. Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.
Cambruzzi E
World Neurosurg; 2020 Feb; 134():215-220. PubMed ID: 31605845
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
Wang C; Li W; Liu C; He H; Bai O
Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
[TBL] [Abstract][Full Text] [Related]
4. Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.
Zhang YA; Yang X; Yao J; Ren Y; Liu P
Dis Markers; 2022; 2022():3276925. PubMed ID: 35774848
[TBL] [Abstract][Full Text] [Related]
5. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
6. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
[TBL] [Abstract][Full Text] [Related]
7. [The clinical characteristics of 681 patients with diffuse large B-cell lymphoma].
Wen JJ; Liu ZB; Xu J; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1004-9. PubMed ID: 23363791
[TBL] [Abstract][Full Text] [Related]
8. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
9. [Nodal versus extranodal diffuse large B-cell lymphoma: comparison of clinicopathologic features, immunophenotype and prognosis].
Lu JB; Li XQ; Zhang PH; Zhou XY; Zhang TM; Li XM; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):470-3. PubMed ID: 17845761
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of VEGF and CXCR4 in diffuse large B cell lymphoma and their clinical significances].
Guo Q; Wang JJ; Li F; Yang HL; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):383-6. PubMed ID: 23628037
[TBL] [Abstract][Full Text] [Related]
12. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer.
Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
Ann Oncol; 2007 Jan; 18(1):70-76. PubMed ID: 17032700
[TBL] [Abstract][Full Text] [Related]
13. C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges.
Du H; Gao L; Luan J; Zhang H; Xiao T
Acta Haematol; 2019; 142(2):64-70. PubMed ID: 31096215
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
15. Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.
Shin HC; Seo J; Kang BW; Moon JH; Chae YS; Lee SJ; Lee YJ; Han S; Seo SK; Kim JG; Sohn SK; Park TI
Korean J Intern Med; 2014 Nov; 29(6):785-92. PubMed ID: 25378977
[TBL] [Abstract][Full Text] [Related]
16. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
[TBL] [Abstract][Full Text] [Related]
17. [Expression of CD30 in Patients with Diffuse Large B-Cell Lymphoma and Clinical Significance].
Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
19. Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases.
Strien L; Joensuu K; Heikkilä P; Leidenius MH
Anticancer Res; 2017 Jan; 37(1):175-182. PubMed ID: 28011488
[TBL] [Abstract][Full Text] [Related]
20. Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large B-cell lymphoma.
Wang W; Li Y; Rivera Rivera X; Zhao L; Mei D; Hu W; Jiang B
BMC Cancer; 2021 Sep; 21(1):1011. PubMed ID: 34503477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]